Overview

Loiasis Cross-reactive Antigenemia and Treatment-related Adverse Events

Status:
Completed
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
This study seeks to determine which Loa loa antigens are released into circulation when infected individuals are treated with ivermectin.
Phase:
Phase 4
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
Centre de Recherche sur les Filarioses et autres Maladies Tropicales (CRFilMT)
Treatments:
Ivermectin